Show simple item record

dc.contributor.authorDaniels, R
dc.contributor.authorCottin, J
dc.contributor.authorKhanafer, N
dc.date.accessioned2024-07-02T14:07:42Z
dc.date.issued2023-05-28
dc.date.updated2024-07-01T17:40:11Z
dc.description.abstractBackground: In 2020, health systems across the world responded to the COVID-19 pandemic by making rapid changes to reduce the risk of exposure in patients and healthcare professionals. The use of point-of-care tests (POCT) has been a central strategy in dealing with the COVID-19 pandemic. The aims of this study were to evaluate the impact of POCT strategy (1) on maintaining elective surgeries by removing the risk of delayed pre-appointment testing and turn-around times and (2) on time dedicated for end-to-end appointment and management, and (3) to assess the feasibility of using the ID NOW® among healthcare professionals and patients in a primary care setting, requiring pre-surgical appointment and minor ENT surgery in the Townsend House Medical Centre (THMC), Devon, United Kingdom. Methods: A logistic regression was performed to identify factors associated with the risk of canceled or delayed surgeries and medical appointments. Second, a multivariate linear regression analysis was conducted to calculate changes in the time dedicated to administrative tasks. A questionnaire was developed to assess the acceptance of POCT in patients and staff. Results: 274 patients were included in this study; 174 (63.5%) in Group 1 (Usual Care) and 100 (36.5%) in Group 2 (Point of Care). Multivariate logistic regression showed that the percentage of postponed or canceled appointments was similar between the two groups (adjusted OR = 0.65, [95%CI: 0.22-1.88]; p = 0.42). Similar results were observed for the percentage of postponed or canceled scheduled surgeries (adjusted OR = 0.47, [95%CI: 0.15-1.47]; p = 0.19). The time dedicated to administrative tasks was significantly lowered by 24.7 min in G2 compared to G1 (p < 0.001). 79 patients in G2 (79.0%) completed the survey, and the majority agreed or strongly agreed that it improved care management (79.7%), decreased administrative time (65.8%), reduced the risk of canceled appointments (74.7%) and the traveling time to do COVID-19 test (91.1%). Having point-of-care testing in the clinic in the future seemed more than welcome by 96.6% of patients; 93.6% declared to be less stressed by having the test at the clinic than waiting for the results of the test realized elsewhere. The five healthcare professionals of the primary care center completed the survey, and all agreed that the POCT positively influences the workflow and can be successfully implemented into routine primary care. Conclusions: Our study shows that NAAT-based point-of-care SARS-CoV-2 testing significantly improved flow management in a primary care setting. POC testing was a feasible and well-accepted strategy by patients and providers.en_GB
dc.description.sponsorshipAbbott Rapid Diagnosticsen_GB
dc.format.extent1888-
dc.format.mediumElectronic
dc.identifier.citationVol. 13 (11), article 1888en_GB
dc.identifier.doihttps://doi.org/10.3390/diagnostics13111888
dc.identifier.urihttp://hdl.handle.net/10871/136542
dc.identifierORCID: 0000-0002-6556-3686 (Daniels, Rob)
dc.language.isoenen_GB
dc.publisherMDPIen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37296741en_GB
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/en_GB
dc.subjectCOVID-19en_GB
dc.subjectSARS-CoV-2en_GB
dc.subjectimplementationen_GB
dc.subjectpoint-of-care-testen_GB
dc.subjectprimary careen_GB
dc.titlePoint-of-Care Testing for SARS-CoV-2: A Prospective Study in a Primary Health Centreen_GB
dc.typeArticleen_GB
dc.date.available2024-07-02T14:07:42Z
exeter.article-numberARTN 1888
exeter.place-of-publicationSwitzerland
dc.descriptionThis is the final version. Available from MDPI via the DOI in this record.en_GB
dc.descriptionData Availability Statement. The data are not publicly available due to data privacy restrictions in relation to information on the health of the subjects.en_GB
dc.identifier.eissn2075-4418
dc.identifier.journalDiagnosticsen_GB
dc.relation.ispartofDiagnostics (Basel), 13(11)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-05-26
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-05-28
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-02T08:21:59Z
refterms.versionFCDVoR
refterms.dateFOA2024-07-02T14:07:46Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-05-28


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/
Except where otherwise noted, this item's licence is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/